WFH and HFI Unite Experts to Advance Extended Half-Life Hemophilia Treatment Across North and North-East India
World Federation of Hemophilia (WFH) shared an honoring post on LinkedIn:
”It was an honor to join the President of the World Federation of Hemophilia (WFH), the President of Hemophilia Federation (India) Mr Premroop Alva, and Dr. Cecil Ross (Hematologist, St. John’s Hospital, Bangalore and VP–Medical, HFI) in organizing a combined event at Hotel Le Meridien, Windsor Place, Janpath Road focused on Hemophilia treatment using extended half-life (EHL) products for the North and North-Eastern regions of India.
We were privileged to have eminent experts with us:
Dr. Alok Shrivastava – Renowned Hematologist in India and World
Dr. Nita Radhakrishna – Pediatric Hematologist, PGI Noida
Dr. Shashikant Apte – Hematologist, Sahyadri Hospital, Pune
Dr. Mukul Aggarwal – Hematologist, AIIMS Delhi
Dr. Vipin Kulkarni – ICMR, Mumbai
…and many other dedicated doctors from Hemophilia Treatment Centres receiving humanitarian aid support.
Special thanks to Dr. Steven Pipe and Dr. Jay Martin (Head, WFH Humanitarian Aid Programme), Mr Harshal Kale for their leadership, along with the President of HFI, the technical team, HFI staff, and WFH colleagues for making this event possible.
As CEO of HFI, I am proud to be on the path of raising awareness, building capacity among healthcare providers, and advancing better hemophilia treatment and care across India.”
Stay updated with Hemostasis Today.
-
Oct 10, 2025, 16:15Roshan PK: Breaking Down Pulmonary Embolism Treatment By Risk Level
-
Oct 10, 2025, 12:21Chris Barber Echoes PPTA’s Call to Recognize the Lifesaving Work of Plasma Collection Teams Worldwide
-
Oct 10, 2025, 12:14William Aird: Thalassemia Trait is a Quiet Experiment of Nature
-
Oct 9, 2025, 19:53Wilfried Dinh: Top 10 Thrombosis And Antithrombotic Therapy Papers Of 2024
-
Oct 9, 2025, 13:12Abdul Mannan - Ferritin After IV Iron: Timing Matters
-
Oct 10, 2025, 12:23Bhavya Venkatesh: Talin Autoinhibition Is Required For Normal Hemostasis
-
Oct 10, 2025, 12:19Divyaswathi Citla Sridhar: Excited to Share Our Multicenter Study on Platelet Function Disorders, Now Published
-
Oct 10, 2025, 12:18Roberta Gualtierotti: We Evaluated Different Variables of the Cleaved HK Method in C1-Inhibitor Defects
-
Oct 10, 2025, 12:17Jamie Madrigal And The Team - Mathematical Analysis Of Emicizumab: Affinity-Driven Complex Formation And Lipid-Surface Reactions
-
Oct 10, 2025, 03:09Giuseppe Lippi: We Show Here That Red Light Therapy Offers Promise in High-Risk Patients
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 10, 2025, 03:10Marilena Vrana: Plasma-Derived Medicines Are a Clear Example of Why A One-Size-Fits-All Approach Won’t Work
-
Oct 10, 2025, 03:07Nancy Di Salvo: It's IPAW 2025, How Could I Not Take a Moment to Thank Every Single Plasma Donor Out There?
-
Oct 10, 2025, 03:06Anita Brikman: Increasing Awareness of The Ongoing Need for Plasma Donors Is Vital to Ensuring Patient Access and Continuity of Care
-
Oct 10, 2025, 03:04Stephen Cornelissen: A New Plasma Drop Has Been Added to Lifeblood’s Blood Supply Tracker
-
Oct 10, 2025, 02:12Bethany Samuelson Bannow Welcomed to Department of Hematology and Medical Oncology at the Cancer Institute Cleveland Clinic